Detalhe da pesquisa
1.
Which advanced treatment should be used following the failure of a first-line anti-TNF in patients with rheumatoid arthritis? 15 years of evidence from the Quebec registry RHUMADATA.
Rheumatology (Oxford)
; 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38830031
2.
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).
J Rheumatol
; 51(5): 479-487, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359937
3.
Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data.
Clin Exp Rheumatol
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38855967
4.
Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada.
BMJ Open
; 13(3): e063198, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878650
5.
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.
J Rheumatol
; 49(1): 16-25, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34334357
6.
Cost-utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis.
Curr Med Res Opin
; 37(1): 157-166, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33136462
7.
Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study.
J Gen Intern Med
; 24(1): 33-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18937013
8.
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry.
Arthritis Res Ther
; 21(1): 138, 2019 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171024
9.
Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
Arch Intern Med
; 167(21): 2296-303, 2007 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-18039987
10.
Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants.
J Bone Miner Res
; 33(8): 1444-1449, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29637622
11.
Estimating the cost effectiveness of ramipril used for specific clinical indications: comparing the outcomes in four clinical trials with a common economic model.
Am J Cardiovasc Drugs
; 7(6): 441-8, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18076211
12.
Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?
Can J Cardiol
; 23(6): 467-73, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17487292
13.
The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.
Arch Intern Med
; 166(2): 213-9, 2006 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-16432091
14.
Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy.
Am J Cardiol
; 95(5): 586-91, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15721096
15.
Cost-effectiveness of lipid-lowering treatment according to lipid level.
Can J Cardiol
; 21(8): 681-7, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16003451
16.
The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?
Arch Intern Med
; 163(3): 333-9, 2003 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12578514
17.
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer.
Clin Cancer Res
; 21(11): 2591-600, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25733599
18.
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor.
Am J Med
; 115(2): 122-8, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12893398
19.
Application of the 1998 Canadian cholesterol guidelines to a military population: health benefits and cost effectiveness of improved cholesterol management.
Can J Cardiol
; 19(7): 790-6, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12813612
20.
Estimating the benefits of patient and physician adherence to cardiovascular prevention guidelines: the MyHealthCheckup Survey.
Can J Cardiol
; 27(2): 159-66, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21459263